The first stop for professional medicines advice

Intrathecal medicines

32 results

Applied filters

Cytarabine: informing intrathecal risk assessment

11 August 2022Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Levobupivacaine: informing intrathecal risk assessment

11 August 2022Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Amikacin: informing intrathecal risk assessment

11 August 2022Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Colistimethate sodium: informing intrathecal risk assessment

11 August 2022Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ziconotide: informing intrathecal risk assessment

16 May 2025Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Intrathecal administration

All our advice on using intrathecal medicines safely.

Ropivacaine: informing intrathecal risk assessment

11 August 2022Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Diamorphine hydrochloride: informing intrathecal risk assessment

11 August 2022Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Gentamicin: informing intrathecal risk assessment

11 August 2022Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone acetate: informing intrathecal risk assessment

11 August 2022Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration